The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size.
The efficacy of receptor tyrosine kinase EphA2 autophosphorylation increases with EphA2 oligomer size.
复制标题
DOI:
10.1016/j.jbc.2022.102370
复制
发表时间:
2022-10
影响因子:
4.8
通讯作者:
Hristova, Kalina
中科院分区:
文献类型:
--
作者:
Zapata-Mercado, Elmer;Biener, Gabriel;McKenzie, Daniel M.;Wimley, William C.;Pasquale, Elena B.;Raicu, Valerica;Hristova, Kalina
The receptor tyrosine kinase (RTK) EphA2 is expressed in epithelial and endothelial cells and controls the assembly of cell–cell junctions. EphA2 has also been implicated in many diseases, including cancer. Unlike most RTKs, which signal predominantly as dimers, EphA2 readily forms high-order oligomers upon ligand binding. Here, we investigated if a correlation exists between EphA2 signaling properties and the size of the EphA2 oligomers induced by multiple ligands, including the widely used ephrinA1-Fc ligand, the soluble monomeric m-ephrinA1, and novel engineered peptide ligands. We used fluorescence intensity fluctuation (FIF) spectrometry to characterize the EphA2 oligomer populations induced by the different ligands. Interestingly, we found that different monomeric and dimeric ligands induce EphA2 oligomers with widely different size distributions. Our comparison of FIF brightness distribution parameters and EphA2 signaling parameters reveals that the efficacy of EphA2 phosphorylation on tyrosine 588, an autophosphorylation response contributing to EphA2 activation, correlates with EphA2 mean oligomer size. However, we found that other characteristics, such as the efficacy of AKT inhibition and ligand bias coefficients, appear to be independent of EphA2 oligomer size. Taken together, this work highlights the utility of FIF in RTK signaling research and demonstrates a quantitative correlation between the architecture of EphA2 signaling complexes and signaling features.
登录
查看更多内容
影响因子:
7.7
作者:
Huang, Yongjian;Bharill, Shashank;Kuriyan, John
通讯作者:
Kuriyan, John
DOI:
10.1146/annurev-pharmtox-011112-140226
发表时间:
2015
影响因子:
12.5
作者:
Barquilla A;Pasquale EB
通讯作者:
Pasquale EB
影响因子:
6.5
作者:
Gordon, Kristin;Kochkodan, James J.;Getsios, Spiro
通讯作者:
Getsios, Spiro
影响因子:
5
作者:
Kenakin, Terry;Watson, Christian;Novick, Steven
通讯作者:
Novick, Steven
影响因子:
37.8
作者:
Finney AC;Funk SD;Green JM;Yurdagul A Jr;Rana MA;Pistorius R;Henry M;Yurochko A;Pattillo CB;Traylor JG;Chen J;Woolard MD;Kevil CG;Orr AW
通讯作者:
Orr AW